Ten years after the end of the 1000 Genomes Project, brand new insights emerge from its sample set, providing a more complete view of human genetic ...

What is CMOS 2.0? At its core, CMOS 2.0 is an effort to move beyond the limitations of a single monolithic die. Rather than ...

NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce extremely positive antimony (“Antimony”, “Sb”) metallurgical testwork results at its oxide ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...